In males, androgen signaling can counteract NAFLD development and progression even by suppressing hepatic inflammation through the inhibition of JNK and NF-κB signaling [420,437]. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.